Commitment COM-393
Post-approval commitment for CDSCO-2022-0093. Category: Risk Management. Priority: low.
Commitment ID
COM-393
Application
Authority
Central Drugs Standard Control Organisation
Category
Risk Management
Priority
low
Status
Overdue
Due Date
2025-03-23
Completed At
—
Owner
Marcus Webb
Created
2022-05-28
Description
Provide carcinogenicity study report for 2-year rat study
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.